Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet

A kind of technology of levocetirizine and dextro-ibuprofen, which is applied in the field of pharmaceutical compositions for treating colds

Active Publication Date: 2007-11-21
XIAN LIJUN PHARMA CO LTD
View PDF0 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although both chlorpheniramine and loratadine can effectively relieve runny nose and sneezing caused by colds, these two antihistamines are ineffective for nasal congestion. As a last resort, it is necessary to combine adrenaline-like nasal congestion relievers, such as Clariflu (contains acetaminophen, loratadine, pseudoephedrine)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet
  • Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet
  • Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0082] Compound Dexibuprofen / Levocetirizine Dihydrochloride Double Layer Tablets (administered once every 12 hours, 2 tablets at a time)

[0083] Immediate Release Layer Prescription

Dexibuprofen

60g

Levocetirizine dihydrochloride

1.25g

lactose

59.75g

microcrystalline cellulose

40g

compressible starch

25g

Crospovidone

12g

8% povidone K30 in 95% ethanol solution

Appropriate amount

silica

1g

Magnesium stearate

1g

Slow-release layer prescription

Dexibuprofen (or its pharmaceutically acceptable salt)

140g

Hydroxypropyl Methyl Cellulose K100m

12.5g

Hydroxypropyl Methyl Cellulose K4m

12.5g

lactose

45g

microcrystalline cellulose

20g

compressible starch

18g

Food coloring (such as sunset yellow aluminum tint, etc.)

Appropriate amount

8% polyvinylpyrrolidone 70% ethanol solution

...

Embodiment 2

[0088] Compound Dexibuprofen / Levocetirizine Dihydrochloride Double Layer Tablets (administered once every 12 hours, 2 tablets at a time)

[0089] Immediate Release Layer Prescription

Dexibuprofen

70g

Levocetirizine dihydrochloride

1.25g

lactose

49.75g

microcrystalline cellulose

40g

compressible starch

25g

Croscarmellose Sodium

12g

silica

1g

Magnesium stearate

1g

Slow-release layer prescription

Dexibuprofen (or its pharmaceutically acceptable salt)

130g

Hydroxypropyl Methyl Cellulose K15m

25g

Ethyl cellulose

25g

lactose

30g

microcrystalline cellulose

20g

compressible starch

18g

Food coloring (such as sunset yellow aluminum tint, etc.)

Appropriate amount

8% polyvinylpyrrolidone 80% ethanol solution

Appropriate amount

silica

1g

Magnesium stearate

1g

...

Embodiment 3

[0094] Compound Dexibuprofen / Levocetirizine Dihydrochloride Double Layer Tablets (administered once every 12 hours, 2 tablets at a time)

[0095] Immediate Release Layer Prescription

Dexibuprofen

50g

Levocetirizine dihydrochloride

1.25g

lactose

69.75g

microcrystalline cellulose

40g

compressible starch

25g

Sodium Hydroxymethyl Starch

12g

95% ethanol

Appropriate amount

silica

1g

Magnesium stearate

1g

Slow-release layer prescription

Dexibuprofen (or its pharmaceutically acceptable salt)

150g

Hydroxypropyl Methyl Cellulose K100m

20g

lactose

40g

microcrystalline cellulose

20g

compressible starch

18g

Food coloring (such as sunset yellow aluminum tint, etc.)

Appropriate amount

8% polyvinylpyrrolidone 75% ethanol solution

Appropriate amount

silica

1g

Magnesium stearate...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Hardnessaaaaaaaaaa
Login to view more

Abstract

The invention is concerned with a kind of chiral compound and its sustained and controlled release double deck pieces compound with (S)-ibuprofen and levocetirizine. The weight ratio of the both is 50:1 to 500:1, and the said troche has two layers and one layer is the sustained and controlled release part made of (S)-ibuprofen, levocetirizine dihydrochloride and acceptable rapidly release assistant stuff. It can collapse quickly to be absorbed by body to take effect and work with antipyretic and analgesic effects, lighten sneezing, nasal stiffness and rhinocnesmus. The other layer is controlled release layer made on (S)-ibuprofen and acceptable controlled release assistant stuff. It can release with sustained and controlled in body to keep the concentration of blood and medicine in body of (S)-ibuprofen and work with antipyretic and analgesic effects to reduce the symptom of cold.

Description

technical field [0001] The present invention relates to a kind of pharmaceutical composition for treating common cold, especially a kind of composition containing dexibuprofen or its pharmaceutically acceptable salt and levocetirizine dihydrochloride, the weight ratio range of the two is 50:1 to 500:1, made into an oral sustained-rapid release double-layer tablet suitable for taking. Background technique [0002] Ibuprofen is a phenylpropionic acid non-steroidal antipyretic, analgesic and anti-inflammatory drug. Receptivity is good. Pseudoephedrine has the effect of selectively constricting blood vessels, which can eliminate congestion and swelling of nasopharyngeal mucosa and relieve nasal congestion symptoms. Therefore, ibuprofen and pseudoephedrine often form compound oral preparations and are widely used in the treatment of symptoms such as fever, headache, sore limbs, and nasal congestion caused by colds. [0003] However, the safety of ibuprofen oral preparations st...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/192A61K31/495A61K9/20A61P29/00A61P11/00
Inventor 吴秦熊晓云赵振伟张强宗周云吕维莲宜冰高湘
Owner XIAN LIJUN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products